Discount sale is live
all report title image

LYSOZYME MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Lysozyme Market, By Therapeutic Application (Anti-infective Therapies, Anti-inflammatory Therapies, Gastrointestinal Infection Management, Respiratory Infection Management, Wound-Healing and Tissue Repair, Immunomodulatory Applications, and Other Therapeutic Uses), By Product Type (Recombinant Lysozyme and Natural Lysozyme), By Form (Lysozyme Solution and Lysozyme Powder), By Route of Administration (Oral, Parenteral, Topical, and Others (Nasal)), By Formulation Type (Monotherapies and Combination Therapies), By End User (Pharmaceutical Manufacturers, Biotechnology Companies, Hospitals and Clinics, and Research Institutes), By Distribution Channel (Online and Offline), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In : Nov 2025
  • Code : CMI9004
  • Pages :165
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical
    • 역사적 범위: 2020 - 2024
    • 예측 기간: 2025 - 2032
Ingographics Image

The global lysozyme market is estimated to be valued at USD 605.9 Mn in 2025 and is expected to reach USD 992.2 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. The global lysozyme market represents a significant segment within the biotechnology and pharmaceutical industries, driven by the multifunctional properties of this naturally occurring antimicrobial enzyme. Lysozyme, primarily derived from egg whites, human secretions, and bacterial sources, serves as a crucial component in various applications ranging from food preservation to pharmaceutical formulations. This enzyme's ability to break down bacterial cell walls makes it an invaluable asset in combating microbial infections and extending product shelf life across multiple industries.

The market encompasses diverse product types including egg white lysozyme, human lysozyme, and recombinant lysozyme, each serving specific industrial requirements. Key application sectors include food and beverages, pharmaceuticals, personal care products, and animal feed, where lysozyme's natural antimicrobial properties provide sustainable alternatives to synthetic preservatives. The increasing consumer preference for natural ingredients, coupled with stringent regulatory frameworks governing food safety and pharmaceutical quality, has positioned lysozyme as a preferred choice for manufacturers seeking effective yet natural antimicrobial solutions. The market's growth trajectory is further supported by advancing biotechnology research, innovative production methods, and expanding applications in emerging therapeutic areas, making it a dynamic and evolving sector with substantial commercial potential.

Market Dynamics

The global lysozyme market is propelled by several key drivers that collectively contribute to its robust growth trajectory, with the primary driver being the escalating demand for natural antimicrobial agents across food, pharmaceutical, and personal care industries as consumers increasingly prioritize clean-label products and manufacturers seek alternatives to synthetic preservatives. The expanding food and beverage sector, particularly in developing economies, creates substantial opportunities for lysozyme application in food preservation, while the growing pharmaceutical industry's focus on natural therapeutic compounds drives demand for pharmaceutical-grade lysozyme in drug formulations and wound healing applications. Additionally, the rising awareness of antibiotic resistance has positioned lysozyme as an attractive alternative antimicrobial agent, supported by extensive research demonstrating its efficacy against various pathogenic microorganisms.

However, the market faces significant restraints including the high production costs associated with lysozyme extraction and purification processes, which limit its adoption in cost-sensitive applications and emerging markets. Raw material availability constraints, particularly concerning egg white sources, pose supply chain challenges, while regulatory complexities across different regions create barriers to market entry and product standardization. The limited shelf stability of lysozyme under certain conditions and potential allergenic reactions in sensitive individuals further constrain market expansion. Nevertheless, substantial opportunities emerge from advancing biotechnology enabling recombinant lysozyme production, which addresses supply limitations and allergenicity concerns while potentially reducing production costs. The expanding nutraceutical market, growing applications in veterinary medicine, increasing adoption in developing regions, and potential therapeutic applications in treating various diseases present lucrative growth avenues for market participants seeking to capitalize on lysozyme's diverse functional properties.

Key Features of the Study

  • This report provides in-depth analysis of the global lysozyme market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lysozyme market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include dsm-firmenich, Bioseutica BV, WAKO Chemicals, Danish Bioscience, Qingdao Vland Biotech, Amano Enzyme Inc, Lysozyme Corporation, Nanning Doing-Higher Bio-Tech, Jiangsu Yiming Biological, Jiangxi Shineway Pharmaceutical, Handary SA, Bouwhuis Enthoven, AgraFood Ingredients BV, Neova Technologies, and Chr Hansen A/S
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lysozyme market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lysozyme market

Market Segmentation

  • Therapeutic Application Insights (Revenue, USD Mn, 2020 - 2032)
    • Anti-infective Therapies
    • Anti-inflammatory Therapies
    • Gastrointestinal Infection Management
    • Respiratory Infection Management
    • Wound-Healing and Tissue Repair
    • Immunomodulatory Applications
    • Other Therapeutic Uses
  • Product Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Recombinant Lysozyme
    • Natural Lysozyme
  • Form Insights (Revenue, USD Mn, 2020 - 2032)
    • Lysozyme Solution
    • Lysozyme Powder
  • Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
    • Oral
    • Parenteral
    • Topical
    • Others (Nasal)
  • Formulation Type Insights (Revenue, USD Mn, 2020 - 2032)
    • Monotherapies
    • Combination Therapies
  • End User Insights (Revenue, USD Mn, 2020 - 2032)
    • Pharmaceutical Manufacturers
    • Biotechnology Companies
    • Hospitals and Clinics
    • Research Institutes
  • Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
    • Online
    • Offline
  • Regional Insights (Revenue, USD Mn, 2020 - 2032)
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa
  • Key Players Insights
    • dsm-firmenich
    • Bioseutica BV
    • WAKO Chemicals
    • Danish Bioscience
    • Qingdao Vland Biotech
    • Amano Enzyme Inc
    • Lysozyme Corporation
    • Nanning Doing-Higher Bio-Tech
    • Jiangsu Yiming Biological
    • Jiangxi Shineway Pharmaceutical
    • Handary SA
    • Bouwhuis Enthoven
    • AgraFood Ingredients BV
    • Neova Technologies
    • Chr Hansen A/S

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global Lysozyme Market, By Therapeutic Application
      • Global Lysozyme Market, By Product Type
      • Global Lysozyme Market, By Form
      • Global Lysozyme Market, By Route of Administration
      • Global Lysozyme Market, By Formulation Type
      • Global Lysozyme Market, By End User
      • Global Lysozyme Market, By Distribution Channel
      • Global Lysozyme Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
    • Driver
    • Restraint
    • Opportunity
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
    • Industry Trends
  4. Global Lysozyme Market, By Therapeutic Application, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Anti-infective Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Anti-inflammatory Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Gastrointestinal Infection Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Respiratory Infection Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Wound-Healing and Tissue Repair
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Immunomodulatory Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Other Therapeutic Uses
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  5. Global Lysozyme Market, By Product Type, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Recombinant Lysozyme
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Natural Lysozyme
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  6. Global Lysozyme Market, By Form, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Lysozyme Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Lysozyme Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  7. Global Lysozyme Market, By Route of Administration, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Others (Nasal)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  8. Global Lysozyme Market, By Formulation Type, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Monotherapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Combination Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  9. Global Lysozyme Market, By End User, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Pharmaceutical Manufacturers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Hospitals and Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  10. Global Lysozyme Market, By Distribution Channel, 2020-2032, (USD Mn)
    • Introduction
      • Market Share Analysis, 2025 and 2032 (%)
      • Y-o-Y Growth Analysis, 2021 - 2032
      • Segment Trends
    • Online
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
    • Offline
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
  11. Global Lysozyme Market, By Region, 2020 - 2032, Value (USD Mn)
    • Introduction
      • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Formulation Type, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  12. Competitive Landscape
    • dsm-firmenich
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bioseutica BV
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WAKO Chemicals
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Danish Bioscience
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Qingdao Vland Biotech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Amano Enzyme Inc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Lysozyme Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Nanning Doing-Higher Bio-Tech
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Jiangsu Yiming Biological
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Jiangxi Shineway Pharmaceutical
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Handary SA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Bouwhuis Enthoven
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AgraFood Ingredients BV
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Neova Technologies
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Chr Hansen A/S
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  13. Analyst Recommendations
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  14. References and Research Methodology
    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘Lysozyme Market' - Global forecast to 2032

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered

860519526

Clutch
Credibility and Certification
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2025 Coherent Market Insights Pvt Ltd. All Rights Reserved.